Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical methods for two-sequence three-period cross-over designs with incomplete data

S C Chow1, J Shao

  • 1Bristol-Myers Squibb Company, Plainsboro, New Jersey 08536, USA.

Statistics in Medicine
|May 15, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

[Impact of father involvement in childcare on maternal parenting stress for children aged 6 to 24 months in rural areas of Zhejiang Province].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

[Safety study of navigation-assisted medial "in-out-in" technique in C<sub>2</sub> screw fixation].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

[The clinical effect of three dimensional print guided F/B-TEVAR vascular endoluminal repair of anastomotic leaks after open surgery for type A aortic dissection].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

[Prevalence of sarcopenia and influencing factors in middle-aged and older adults in Zhejiang Province].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025
Same author

[Development of a grading diagnostic model for schistosomiasis-induced liver fibrosis based on radiomics and clinical laboratory indicators].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2024
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study introduces a new statistical method for analyzing incomplete replicate crossover designs in clinical trials. The method provides exact confidence intervals for treatment and carry-over effects, even with missing data.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacokinetics

Background:

  • Replicate crossover designs are common in clinical trials for drug formulation assessment.
  • Missing data due to dropouts can complicate standard statistical analyses in these designs.

Purpose of the Study:

  • To develop a robust statistical method for analyzing incomplete replicate crossover designs.
  • To enable accurate inference on treatment and carry-over effects despite missing data.

Main Methods:

  • Proposed a novel method based on observation differences to eliminate random subject effects.
  • The method avoids distributional assumptions on random subject effects.
  • Ensures exact confidence intervals for treatment and carry-over effects.

Related Experiment Videos

Main Results:

  • The proposed method yields identical results to ordinary least squares when data is complete.
  • Provides exact confidence intervals for treatment and carry-over effects with missing data.
  • The method's validity is maintained if dropouts are independent of measurement errors.

Conclusions:

  • The new statistical approach effectively handles missing data in replicate crossover trials.
  • It offers a reliable way to assess drug formulation effects and carry-over effects.
  • Applicable to bioavailability and bioequivalence studies with incomplete datasets.